# Carmine DeNardo

> Carmine DeNardo is a pharmacist and healthcare operator whose career has centered on making complex pharmacy services work at scale. After helping build CVS Caremark specialty operations, he led ReCept Pharmacy from $32 million to more than $600 million in revenue, stayed through its $100 million acquisition by Omnicell, and became president and CEO of Medix Infusion in April 2026. His public record is unusually consistent: plan early, build repeatable systems, and keep the patient experience close to the operating model.

- **Role:** President and Chief Executive Officer at Medix Infusion
- **Organizations:** Medix Infusion, Omnicell, ReCept Pharmacy, CVS Caremark, National Association of Specialty Pharmacy
- **Education:** Bachelor of Science in Pharmacy, Northeastern University
- **Known for:** Scaled ReCept Pharmacy revenue from $32 million to more than $600 million., Guided ReCept through private equity investment and its acquisition by Omnicell in a $100 million transaction., Helped launch and scale the PharmaCare Specialty Pharmacy business at CVS Health and oversaw specialty retail locations across 25 states.

## Career timeline

- **1985-2009** — Held operations leadership roles within CVS Caremark businesses, including CVS ProCare, PharmaCare Specialty Operations and TheraCom; eventually served as chief operating officer of TheraCom and oversaw specialty retail operations across 25 states.
- **2009** — Joined ReCept Pharmacy to oversee national growth and strategic expansion.
- **2012** — Was documented as president and chief executive officer of ReCept Holdings in an SEC Form D filing.
- **2015** — Led ReCept as it reported $151.4 million in 2014 sales and reached No. 14 on the Fort Worth Business Top 100 list after climbing 26 places.
- **2018-2020** — Served as chairman of the board of the National Association of Specialty Pharmacy.
- **2021** — Guided ReCept into a definitive agreement to be acquired by Omnicell for $100 million.
- **2022-2026** — Served as vice president and general manager of Omnicell's specialty pharmacy business, leading integration and expansion of ReCept.
- **2022** — Received the National Association of Specialty Pharmacy Distinguished Service Award.
- **2026** — Appointed president and chief executive officer of Medix Infusion on April 28.

## Achievements

- Scaled ReCept Pharmacy revenue from $32 million to more than $600 million.
- Guided ReCept through private equity investment and its acquisition by Omnicell in a $100 million transaction.
- Helped launch and scale the PharmaCare Specialty Pharmacy business at CVS Health and oversaw specialty retail locations across 25 states.
- Served as chairman of the National Association of Specialty Pharmacy board from 2018 to 2020.
- Received the National Association of Specialty Pharmacy Distinguished Service Award in 2022.
- Has more than 35 years of executive leadership experience in retail and specialized pharmacy services.

## Latest updates

- **2026-04** — Medix Infusion appointed DeNardo president and chief executive officer.
- **2025-03** — As an Omnicell executive, DeNardo commented on a collaboration with ACHC offering health systems a readiness assessment and pathway toward Specialty Pharmacy Accreditation.
- **2024-07** — Published a MedCity News article arguing that health-system-owned specialty pharmacies can improve access, operations and financial performance when supported by the right expertise and technology.

## Links

- Website: https://medixinfusion.com/team/carmine-denardo/
- LinkedIn: https://www.linkedin.com/in/carmine-denardo-b28ba117

---

Profile page: https://yespress.io/carmine-denardo
Published by YesPress — https://yespress.io
Last updated: 2026-09-27